Concepedia

Günther Kern

GK

28

Publications

2.4K

Citations

21

H-Index

1992

Active since

Affiliations

AstraZeneca (United States)(Current)

University of California, Berkeley

Max Planck Research Unit for Enzymology of Protein Folding

Martin Luther University Halle-Wittenberg

University of Bayreuth

Günther Kern is an author at AstraZeneca (United States) specializing in medicine, natural sciences, and drug discovery.

Top concepts

MedicineNatural SciencesBiochemistryDrug DiscoveryMolecular BiologyPharmacologyAntimicrobial Drug DiscoveryPharmacotherapyProtein FoldingDrug Development

Publications per year

1992–2021

28

Publications

28

Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor

David E. Ehmann, Haris Jahić, Philip L. Ross et al. · Proceedings of the National Academy of Sciences · 2012 · 507 citations · Full text

Identification of 4-Substituted 1,2,3-Triazoles as Novel Oxazolidinone Antibacterial Agents with Reduced Activity against Monoamine Oxidase A

Folkert Reck, Fei Zhou, Marc Girardot et al. · Journal of Medicinal Chemistry · 2005 · 324 citations · Full text

Monoamine Oxidase A, Pharmacotherapy, Antimicrobial Chemotherapy +18

How Thiamine Diphosphate Is Activated in Enzymes

Dorothee Kern, Günther Kern, Holger Neef et al. · Science · 1997 · 286 citations

Exploitation of structural and regulatory diversity in glutamate racemases

T. Lundqvist, Stewart L. Fisher, Günther Kern et al. · Nature · 2007 · 138 citations · Full text

Glutamate Racemases, Natural Sciences, Genetics +6

Kinetic Analysis of Cyclophilin-Catalyzed Prolyl Cis/Trans Isomerization by Dynamic NMR Spectroscopy

Dorothee Kern, Günther Kern, Gerd Scherer et al. · Biochemistry · 1995 · 121 citations

Rows per page

1–5 of 28